Oral-antigen delivery via a water-in-oil emulsion system modulates the balance of the Th1/Th2 type response in oral tolerance

Pharmaceutical Research

Volumn 20, Issue 1, 2003, Pages 130-134

  Masuda, Kazuyoshi ^a   Horie, Kazutoshi ^a   Suzuki, Ryuji ^a   Yoshikawa, Takayoshi ^a   Hirano, Koichiro ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

Oral tolerance; Oral antigen delivery; Ovalbumin; Th1 Th2 balance; W O emulsion

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; OIL; OVALBUMIN; SODIUM CHLORIDE; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; EMULSION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; LYMPH NODE CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS; DRUG DELIVERY SYSTEMS; DRUG TOLERANCE; EMULSIONS; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-4; LYMPH NODES; MALE; MICE; MICE, INBRED BALB C; OILS; OVALBUMIN; TH1 CELLS; TH2 CELLS; WATER;

EID: 0037260575     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022267312869     Document Type: Article

References (18)

1. H. L. Weiner, A. Friedman, A. Miller, S. J. Khory, A. AlSabbagh, L. Santos, M. Sayegh, R. B. Nussenblatt, D. E. Trentham, and D. A. Hafler. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12:809-837 (1994).
2. A. Friedman and H. L. Weiner. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA 91:6688-6692 (1994).
3. J. B. Sun, J. Holmgren, and C. Czerkinsky. Cholera toxin B subunit: An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci. USA 91:10795-10799 (1994).
4. C. O. Elson, M. Tomasi, M. T. Dertzbaugh, G. Thaggard, R. Hunter, and C. Weaver. Oral-antigen delivery by way of a multiple emulsion system enhances oral tolerance. Ann. NY Acad. Sci. 778:156-162 (1996).
5. M. Hashida, S. Muranishi, and H. Sezaki. Evaluation of water in oil and microsphere in oil emulsions as a specific delivery system of 5-fluorouracil into lymphatics. Chem. Pharm. Bull. 25:2410-2418 (1977).
6. K. Masuda, S. Nagata, S. Harada, K. Hirano, and Y. Takagishi. Monoclonal antibodies against human α-fetoprotein more reactive to cell-surface α-fetoprotein than to free α-fetoprotein. Microbiol. Immunol. 36:873-884 (1992).
7. T. R. Mosmann, H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. Two types of murine helper T cell clone I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-2357 (1986).
8. H. Cherwinski, J. H. Schumacher, K. D. Brown, and T. R. Mosmann. Two types of murine helper T cell clone III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229-1244 (1987).
9. T. L. Stevens, A. Bossie, V. M. Sanders, R. Fernandez-Botran, R. L. Coffman, T. R. Mosmann, and E. S. Vitetta. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334:255-258 (1988).
10. + T cells. J. Exp. Med. 183:2669-2674 (1996).
11. C. King, J. Davies, R. Mueller, M.-S. Lee, T. Krahl, B. Yeung, E. O'Connor, and N. Sarvetnick. TGF-β alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity 8:601-613 (1998).
12. C. I. Pearson and H. O. McDevitt. Redirecting Th1 and Th2 responses in autoimmune disease. Curr. Top. Microbiol. Immunol. 238:79-122 (1999).
13. G. Garcia, Y. Komagata, A. J. Slavin, R. Maron, and H. L. Weiner. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen. J. Autoimmun. 13:315-324 (1999).
14. K. Yudoh, H. Matsuno, F. Nakagawa, T. Yonezawa, and T. Kimura. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis. Arthritis Rheum. 43:617-627 (2000).
15. B. Berner, D. Akca, T. Jung, G. A. Muller, and M. A. Reuss-Borst. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. J. Rheumatol. 27:1128-1135 (2000).
16. S. H. Park, D. J. Min, M. L. Cho, W. U. Kim, J. Youn, W. Park, C. S. Cho, and H. Y. Kim. Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis. Arthritis Rheum. 44:561-569 (2001).
17. J. R. McGhee and H. Kiyono. New perspective in vaccine development: mucosal immunity to infections. Infect. Agents Dis. 2:55-73 (1993).
18. D. E. Trentham, R. A. Dynesius-Trentham, E. J. Orav, D. Combitchi, C. Lorenzo, K. L. Sewell, D. A. Hafler, and H. L. Weiner. Effects of type II collagen on rheumatoid arthritis. Science 261:1727-1730 (1993).